Human Tissue Authority

The regulator for human tissue and organs

Human application

Under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (Q&S Regulations), the HTA licenses and inspects establishments that undertake the procurement, testing, processing, storage, distribution, import and export of tissues and cells for human application.

Licensed establishments include a wide range of organisations such as hospitals, stem cell laboratories and tissue banks, as well as private companies such as cord blood banks, suppliers of acellular material and establishments that procure the starting material for Advanced Therapy Medicinal Products (ATMPs). Establishments licensed under the Q&S Regulations work with a wide variety of tissue/cell types, including bone, skin, heart valves, bone marrow, stem cells, chondrocytes, and pancreatic islets.

Licensed establishments are required to meet the standards which are detailed in the HTA’s ‘Guide to Quality and Safety Assurance of Human Tissues and Cells for Patient Treatment’ as implemented by Directions 002/2018. These Directions consolidate and clarify the standards required under the Q&S Regulations.

Guide to Quality and Safety Assurance for Human Tissues and Cells for Patient Treatment
The standards that establishments licensed under an HTA human application licence should meet
What is a TPAIn the Human Application sector, a Third Party Agreement (TPA) may be used to provide an unlicensed third party with the authority to undertake licensable activities on behalf of an appropriately licensed establishment.DefinitionThe Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended) define a TPA as: “An agreement in writing between a licence...
The Regulatory Advice Service for Regenerative Medicine (the Advice Service) is a ‘One Stop Shop’ for research and development professionals across academia, industry and the NHS.
HTA position statement on the regulation of acellular material.
Guidance for establishments licensed under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 who are involved in the procurement, receipt and acceptance of umbilical cord blood.
HTA position statement on the regulation of dendritic cells and white blood cells other than granulocytes under the Human Tissue (Quality and Safety for Human Application) Regulations 2007
HTA position on biological testing requirements for autologous donors of tissues and cells.
Information about the HFEA and HTA's work to reduce the regulatory overlap regarding the storage of ovarian and testicular tissue.

Pages

See also...